CULT Food Science Corp
OTC:CULTF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
CULTF's latest stock split occurred on Jan 16, 2026
The company executed a 1-for-50 stock split, meaning that for every 50 shares held, investors received 1 new share.
Before the split, CULTF traded at 0.1935 per share. Afterward, the share price was about 0.213.
The adjusted shares began trading on Jan 16, 2026. This was CULTF's 2nd stock split, following the previous one in Aug 23, 2023.
Global
Stock Splits Monitor
CULT Food Science Corp
Glance View
Cult Food Science Corp. is an investment company. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2022-01-17. The firm is principally focused on clean, lab-grown food that is advancing the development of technologies to provide solutions to the global factory farming crisis. The firm provides individual investors with an exposure to various start-ups, private or early-stage cultivated meat and cultured dairy companies around the world. The firm's global portfolio spans four continents and includes exposure to a diverse pipeline of cell lines, end products, scaffolding technology, growth medium, and intellectual property (IP) related to the production of cultivated meat, cultured dairy, and cell-based foods. Its platforms consist of CULT Prize and Cell X. CULT Prize is the Company's scientific incubation platform. Cell X is a research and IP aggregation platform with a focus on leveraging biofactory engineering protocols to generate proteins and food inputs.
CUE
3902
MMI